skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreProduct loginProductLogin
Global Search Configuration
Pharmaprojects

RELIABLE SOURCE FOR PHARMA R&D INTELLIGENCE

HOW IT HELPS

The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for over 40 years.

 

With 90,000+ drug profiles, including 20,000 drugs in active development, it’s the go-to resource for tracking and analyzing the global drug research and development landscape across all disease areas from preclinical to launch. 

PHARMAPROJECTS BENEFITS

Icons_Pharma_Arrow_up_SolidPink_RGB Access unrivaled historical detail, enabling you to examine R&D trends
Optimize business development and licensing strategies while identifying new opportunities
Assess the competitive landscape to identify development threats, gaps, or opportunities, and find fallen angels
Monitor major market trends such as drug launches, orphan drug status designations, or discontinuations

HOW IT HELPS

 

Pharmaprojects’ intuitive interface supports fast access to drug development insight for specific diseases, companies, and countries, and can support your strategic decision-making processes.


With our industry-leading platform you can:

  • Leverage dynamic dashboards to analyze trends by key data points
  • Identify fallen angels for in-licensing or partnership opportunities, and conduct your due diligence
  • Actively monitor competitive development and historical timelines, while identifying past successes and failures
  • Get direct access to our leading expert analysts through our ‘Ask the Analyst’ service
     

 

 

 

You can also access Pharmaprojects via our Drugs API so you can integrate, connect, and deliver multiple sources of information in real-time.


Pharmaprojects also offers seamless integration with Trialtrove and Sitetrove, our clinical trials and site/investigator intelligence solutions.

 

 

Pharmaprojects

Pharma R&D Annual Review 2021

Penned for the 29th time by Ian Lloyd – Senior Director, Pharmaprojects, the Pharma R&D Annual Review 2021 is ready to transport you into the pharma R&D universe.

Download
Pharmaprojects

Pharma R&D Annual Review 2021 Supplement: New Active Substances Launched During 2020

This year’s supplement provides detailed statistics, year-on-year trends and insightful analysis on the year’s NAS launches, making this a must-read for the pharma industry.

Download
Pharmaprojects

Pharma R&D Annual Review 2020

Using the new, granular datapoints in Pharmaprojects, Senior Director Ian Lloyd presents his expert insights into pharma’s R&D activities over the past year.

Download
Pharmaprojects

Pharma R&D Annual Review 2020 Supplement: New Active Substances Launched During 2019

Ian Lloyd – Senior Director, Pharmaprojects, shares his expert insights on the new drugs approved for use in patients that made it to market during the year.

Download

Thank you for requesting a demo

We have received your request and we will get back to you soon.

Oops, there appears to be a problem

Request a demo

TC Existing Customer
Terms and Conditions
Additional Fields

Informa Privacy Policy    Informa Terms & Conditions